A company was facing significant challenges in a global clinical trial program with 30 studies for an uncommon indication. Not only did they need to transition all ongoing clinical trials to the Bioclinica Clinical Adjudication platform for better analysis — but they also needed to do it within 60 days.
Download our case study to learn:
- Pain points the client experienced prior to the rescue
- Key results from the transition including transparent oversight, trouble-free images collection and compliance, and comprehensive language support
- Questions you can ask with selecting a partner for event adjudication
Download our case study to learn more about how ensure success for a clinical event adjudication process transition.View Resource